Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PTH(1-34) Treatment on Fracture Healing
NCT00741182Phase 2Withdrawn
- Sponsor
- Rigshospitalet Glostrup
- Start
- Oct 2008
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teriparatide in shoulder fracture, trochanteric fracture, sponsored by Rigshospitalet Glostrup. Planned start Oct 2008; status: withdrawn.
02
Drugs
teriparatide
03
Conditions
shoulder fracturetrochanteric fracture
Beyond the preview
Go deeper on NCT00741182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741182.